Salazar, J., Arranz, M. J., Martin-Broto, J., Serra, M., Palmerini, E., Martínez-García, J., . . . Sebio, A. (2025). VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.
Citación estilo ChicagoSalazar, Juliana, et al. VEGF Signaling Pathway Germline Polymorphisms As Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients From the GEIS-33 Protocol. 2025.
Cita MLASalazar, Juliana, et al. VEGF Signaling Pathway Germline Polymorphisms As Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients From the GEIS-33 Protocol. 2025.
Precaución: Estas citas no son 100% exactas.